Sam joined Royalty Pharma in 2020. Previously, Sam was a vice president in the Healthcare Investment Banking group at Morgan Stanley, covering a variety of companies across the biopharmaceutical industry. Sam has a BS in business administration with a concentration in finance from Northeastern University.
